2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2023-9-4-0-93251Medicine (miscellaneous)<strong>Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review)</strong><strong>Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review)</strong>PonomarenkoMarina S.PonomarenkoMarina S.ponomarenkomc@yandex.ruReshetnikovEvgeny A.ReshetnikovEvgeny A.reshetnikov@bsu.edu.ruChurnosovaMaria M.ChurnosovaMaria M.1647082@bsu.edu.ruReshetnikovaYuliya N.ReshetnikovaYuliya N.resh_yul@mail.ruChurnosovVladimir I.ChurnosovVladimir I.vchurnosov@yandex.kzPonomarenkoIrina V.PonomarenkoIrina V.ponomarenko_i@bsu.edu.ru20239400

Background: Benign proliferative diseases of the female reproductive system (endometriosis, endometrial hyperplasia, and uterine leiomyoma) are comorbid and often occur together. The aim of the study: To establish common risk factors for the development of benign proliferative diseases of the female reproductive system (endometriosis, endometrial hyperplasia, and uterine leiomyoma). Materials and methods: The review includes up-to-date data from articles found in PubMed and Elibrary on this topic. Results: The article reviews the recent literature about factors determining comorbidity and syntropy of the diseases. Their comorbidity may be based on common environmental risk factors (early menarche, body mass index, induced abortions, etc.) and mechanisms of the pathogenesis, which include hormone-dependent cellular proliferation associated with the action of sex hormones and hormone-independent cellular proliferation processes stimulated by growth factors and cytokines, apoptosis, and pathological neoangiogenesis, etc. These common mechanisms are backed by syntropic genes (e.g., FSHB, COMT). Syntropy and pleiotropy appear to be closely related: syntropic genes manifest pleiotropic effects too. Also, epigenetic factors, such as miRNAs are important determinants of the diseased phenotypes. Conclusion: Identification of the shared factors contributing to the benign proliferative diseases of the female reproductive system helps to determine targets for therapeutic intervention and efficient control of the comorbidity.

Background: Benign proliferative diseases of the female reproductive system (endometriosis, endometrial hyperplasia, and uterine leiomyoma) are comorbid and often occur together. The aim of the study: To establish common risk factors for the development of benign proliferative diseases of the female reproductive system (endometriosis, endometrial hyperplasia, and uterine leiomyoma). Materials and methods: The review includes up-to-date data from articles found in PubMed and Elibrary on this topic. Results: The article reviews the recent literature about factors determining comorbidity and syntropy of the diseases. Their comorbidity may be based on common environmental risk factors (early menarche, body mass index, induced abortions, etc.) and mechanisms of the pathogenesis, which include hormone-dependent cellular proliferation associated with the action of sex hormones and hormone-independent cellular proliferation processes stimulated by growth factors and cytokines, apoptosis, and pathological neoangiogenesis, etc. These common mechanisms are backed by syntropic genes (e.g., FSHB, COMT). Syntropy and pleiotropy appear to be closely related: syntropic genes manifest pleiotropic effects too. Also, epigenetic factors, such as miRNAs are important determinants of the diseased phenotypes. Conclusion: Identification of the shared factors contributing to the benign proliferative diseases of the female reproductive system helps to determine targets for therapeutic intervention and efficient control of the comorbidity.

uterine leiomyomaendometriosisendometrial hyperplasiacomorbiditysyntropyuterine leiomyomaendometriosisendometrial hyperplasiacomorbiditysyntropyСписок литературыWise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids: from menarche to menopause. Clinical Obstetrics and Gynecology. 2016;59(1):2-24. DOI: https://doi.org/10.1097/GRF.0000000000000164Sanderson PA, Critchley HOD, Williams ARW, et al. New concepts for an old problem: the diagnosis of endometrial hyperplasia.&nbsp;Human Reproduction Update. 2017;23(2):232-254. DOI: https://doi.org/10.1093/humupd/dmw042Lagan&agrave; AS, Garzon S, G&ouml;tte M, et al. The pathogenesis of endometriosis: molecular and cell biology insights. International Journal of Molecular Sciences. 2019;20(22):5615. DOI: https://doi.org/10.3390/ijms20225615Commandeu AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Human Reproduction Update. 2015;21(5):593-615. DOI: https://doi.org/10.1093/humupd/dmv030Backonja U, Louis GMB, Lauver DR. Overall adiposity, adipose tissue distribution, and endometriosis: a systematic review. Nursing Research. 2016;65(2):151-166. DOI: https://doi.org/10.1097/NNR.0000000000000146Treloar SA, O&#39;Connor DT, O&#39;Connor VM, et al. Genetic influences on endometriosis in an Australian twin sample. Fertility and Sterility. 1999;71(4):701-710. DOI: https://doi.org/10.1016/S0015-0282(98)00540-8Chandra V, Kim JJ, Benbrook DM, et al. Therapeutic options for management of endometrial hyperplasia. Journal of Gynecologic Oncology. 2016;27(1):e8. DOI: https://doi.org/10.3802/jgo.2016.27.e8Epplein M, Reed SD, Voigt LF, et al. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.&nbsp;American Journal of Epidemiology. 2008;168(6):563-576. &nbsp;DOI: https://doi.org/10.1093/aje/kwn168Nezhat C, Li A, Abed S, et al. Strong association between endometriosis and symptomatic leiomyomas. Journal of the Society of Laparoendoscopic Surgeons. 2016;20(3):e2016.00053. DOI: https://doi.org/10.4293/JSLS.2016.00053Geethamala K, Murthy VS, Vani BR, et al. Uterine Leiomyomas: An ENIGMA. Journal of Mid-Life Health. 2016;7(1):22-27. DOI:&nbsp;https://doi.org/10.4103/0976-7800.179170Ponomarenko I, Reshetnikov E, Polonikov A, et al. Candidate genes for age at menarche are associated with endometrial hyperplasia. Gene. 2020;757:144933. DOI: https://doi.org/10.1016/j.gene.2020.144933Ponomarenko I, Reshetnikov E, Polonikov A, et al. Candidate genes for age at menarche are associated with endometriosis. Reproductive BioMedicine Online. 2020;41(5):943-956. DOI: https://doi.org/10.1016/j.rbmo.2020.04.016Song L, Shen L, Mandiwa C, et al. Induced and spontaneous abortion and risk of uterine fibroids. Journal of Women&#39;s Health. 2017;26(1):76-82. DOI: https://doi.org/10.1089/jwh.2016.5913Ross RK, Pike MC, Vessey MP, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. British Medical Journal (Clinical research ed.). 1986;293:359-362. &nbsp;DOI: https://doi.org/10.1136/bmj.293.6543.359Luoto R, Kaprio J, Rutanen EM, et al. Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study.&nbsp;Maturitas. 2000;37(1):15-26. DOI: https://doi.org/10.1016/s0378-5122(00)00160-2Moini A, Malekzadeh F, Amirchaghmaghi E, et al. Risk factors associated with endometriosis among infertile Iranian women. Archives of Medical Science. 2013;9(3):506-514. DOI: https://doi.org/10.5114/aoms.2013.35420Liu Y, Zhang W. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget. 2017;8(29):46928-46936. DOI: https://doi.org/10.18632/oncotarget.14916Nnoaham KE, Webster P, Kumbang J, et al. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of&nbsp;case-control studies. Fertility and Sterility. 2012;98(3):702-712.e6. DOI: https://doi.org/10.1016/j.fertnstert.2012.05.035Ponomarenko I, Reshetnikov E, Altuchova O, et al. Association of genetic polymorphisms with age at menarche in Russian women. Gene. 2019;686:228-236. &nbsp;DOI: https://doi.org/10.1016/j.gene.2018.11.042Alsudairi HN, Alrasheed AT, Dvornyk V. Estrogens and uterine fibroids: an integrated view. Research Results in Biomedicine. 2021;7(2):156-163. DOI: https://doi.org/10.18413/2658-6533-2021-7-2-0-6Douglas NI, Pavlova TU, Burtseva TE, et al. Women&#39;s reproductive health in the Sakha Republic (Yakutia). International Journal of Circumpolar Health. 2014;73(1):25872. DOI: https://doi.org/10.3402/ijch.v73.25872Schneider AP, 2nd Zainer CM, Kubat CK, et al. The breast cancer epidemic: 10 facts. The Linacre quarterly. 2014;81(3):244-277. DOI: https://doi.org/10.1179/2050854914Y.0000000027Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas.&nbsp;International Journal of Gynecology and Obstetrics. 1995;51(2):127-131. DOI: https://doi.org/10.1016/0020-7292(95)02533-IAdachi S, Tajima A, Quan J, et al. Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. Journal of Human Genetics. 2010;55:816-821. &nbsp;DOI: https://doi.org/10.1038/jhg.2010.118Albertsen HM, Chettier R, Farrington P, et al. Genome-wide association study link novel loci to endometriosis. PLoS ONE. 2013;8(3):e58257. DOI: https://doi.org/10.1371/journal.pone.0058257Nyholt DR, Low SK, Anderson CA, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nature Genetics. 2012;44:1355-1359. DOI: https://doi.org/10.1038/ng.2445Painter JN, Anderson CA, Nyholt DR, et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nature Genetics. 2011;43:51-54. DOI: https://doi.org/10.1038/ng.731Uimari O, Rahmioglu N, Nyholt DR, et al. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Human Reproduction. 2017;32(4):780-793. DOI: https://doi.org/10.1093/humrep/dex024Uno S, Zembutsu H, Hirasawa A, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nature Genetics. 2010;42:707-710. DOI: https://doi.org/10.1038/ng.612Sapkota Y, Steinthorsdottir V, Morris AP, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nature Communications. 2017;8:15539. DOI: https://doi.org/10.1038/ncomms15539Masuda T, Low SK, Akiyama M, et al. GWAS of five gynecologic diseases and cross-trait analysis in Japanese. European Journal of Human Genetics. 2020;28:95-107. DOI: https://doi.org/10.1038/s41431-019-0495-1Cha PC, Takahashi A, Hosono N, et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nature Genetics. 2011;43:447-450. DOI: https://doi.org/10.1038/ng.805Rafnar T, Gunnarsson B, Stefansson OA, et al. Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits. Nature Communications. 2018;9:3636. DOI: https://doi.org/10.1038/s41467-018-05428-6V&auml;lim&auml;ki N, Kuisma H, Pasanen A, et al. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. eLife. 2018;7:e37110. DOI: https://doi.org/10.7554/eLife.37110Gallagher CS, M&auml;kinen N, Harris HR, et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.&nbsp;Nature Communications. 2019;10:4857. DOI: https://doi.org/10.1038/s41467-019-12536-4Edwards TL, Giri A, Hellwege JN, et al. A&nbsp;Trans-Ethnic Genome-Wide Association Study of Uterine Fibroids.&nbsp;Frontiers in Genetics. 2019;10:511. DOI: https://doi.org/10.3389/fgene.2019.00511Radzinsky VE, Altuchova OB. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018;4(3):28-37. Russian. DOI: https://doi.org/10.18413/2313-8955-2018-4-3-0-3Golovchenko IO. Genetic determinants of sex hormone levels in endometriosis patients. Research Results in Biomedicine. 2023;9(1):5-21. Russian. DOI: https://doi.org/10.18413/2658-6533-2023-9-1-0-1Ruth KS, Campbell PJ, Chew S, et al. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. European Journal of Human Genetics. 2016;24:284-290. DOI: https://doi.org/10.1038/ejhg.2015.102He C, Kraft P, Chasman DI, Buring JE, et al. A large-scale candidate gene association study of age at menarche and age at natural menopause. Human Genetics. 2010;128:515-527. DOI: https://doi.org/10.1007/s00439-010-0878-4Stolk L, Perry JRB, Chasman DI, et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nature Genetics. 2012;44:260-268. DOI: https://doi.org/10.1038/ng.1051Gajbhiye R, Fung JN, Montgomery GW. Complex genetics of female fertility.&nbsp;npj Genomic Medicine. 2018;3:29. DOI: https://doi.org/10.1038/s41525-018-0068-1Rahmioglu N, Macgregor S, Drong AW, et al. Genome-wide enrichment analysis between endometriosis and obesity-related traits reveals novel susceptibility loci. Human Molecular Genetics. 2015;24(4):1185-1199. DOI: https://doi.org/10.1093/hmg/ddu516Fern&aacute;ndez-Rhodes L, Demerath EW, Cousminer DL, et al. Association of adiposity genetic variants with menarche timing in 92,105 women of European descent. American Journal of Epidemiology. 2013;178(3):451-460. DOI: https://doi.org/10.1093/aje/kws473Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics. 2004;75:807-821. DOI: https://doi.org/10.1086/425589Feng Y, Zha X, Zhou C, et al. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM). Gene. 2013;529(2):296-299. DOI: https://doi.org/10.1016/j.gene.2013.07.019Zhai J, Jiang L, Wen A, et al. Analysis of the relationship between COMT polymorphisms and endometriosis susceptibility. Medicine. 2019;98(1):e13933. DOI: https://doi.org/10.1097/MD.0000000000013933Day FR, Bulik-Sullivan B, Hinds DA, et al. Shared genetic aetiology of puberty timing between sexes and with health-related outcomes. Nature Communications. 2015;6:8842. DOI: https://doi.org/10.1038/ncomms9842Day FR, Elks CE, Murray A, et al. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Scientific Reports. 2015;5:11208. DOI: https://doi.org/10.1038/srep11208Nothnick WB. Non-coding RNAs in Uterine Development, Function and Disease. Advances in experimental medicine and biology. 2016;886:171-189. DOI: https://doi.org/10.1007/978-94-017-7417-8_9